HOTH
Price
$0.80
Change
-$0.04 (-4.76%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
13.01M
Intraday BUY SELL Signals
LIMN
Price
$1.42
Change
+$0.35 (+32.71%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
N/A
Intraday BUY SELL Signals
Interact to see
Advertisement

HOTH vs LIMN

Header iconHOTH vs LIMN Comparison
Open Charts HOTH vs LIMNBanner chart's image
Hoth Therapeutics
Price$0.80
Change-$0.04 (-4.76%)
Volume$1.2K
Capitalization13.01M
Liminatus Pharma
Price$1.42
Change+$0.35 (+32.71%)
Volume$203.7K
CapitalizationN/A
HOTH vs LIMN Comparison Chart in %
HOTH
Daily Signal:
Gain/Loss:
LIMN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HOTH vs. LIMN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOTH is a Hold and LIMN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (HOTH: $0.84 vs. LIMN: $1.07)
Brand notoriety: HOTH and LIMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOTH: 83% vs. LIMN: 3939%
Market capitalization -- HOTH: $13.01M vs. LIMN: $0
HOTH [@Biotechnology] is valued at $13.01M. LIMN’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOTH’s FA Score shows that 1 FA rating(s) are green whileLIMN’s FA Score has 1 green FA rating(s).

  • HOTH’s FA Score: 1 green, 4 red.
  • LIMN’s FA Score: 1 green, 4 red.
According to our system of comparison, both HOTH and LIMN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOTH’s TA Score shows that 3 TA indicator(s) are bullish while LIMN’s TA Score has 5 bullish TA indicator(s).

  • HOTH’s TA Score: 3 bullish, 5 bearish.
  • LIMN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LIMN is a better buy in the short-term than HOTH.

Price Growth

HOTH (@Biotechnology) experienced а -16.97% price change this week, while LIMN (@Biotechnology) price change was +63.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIMN YTD gains are higher at: 75.410 vs. HOTH (-15.293).
HOTHLIMNHOTH / LIMN
Capitalization13MN/A-
EBITDA-11.86MN/A-
Gain YTD-15.29375.410-20%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash7.85MN/A-
Total Debt13.6KN/A-
FUNDAMENTALS RATINGS
HOTH: Fundamental Ratings
HOTH
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOTHLIMN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
19%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
34%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
30%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
23%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
46%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
21%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
HOTH
Daily Signal:
Gain/Loss:
LIMN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA421.960.15
+0.04%
Tesla
AAPL269.48-0.53
-0.20%
Apple
SPY689.53-5.88
-0.85%
State Street® SPDR® S&P 500® ETF
BTC.X75633.550000-3055.218800
-3.88%
Bitcoin cryptocurrency
GME24.52-1.33
-5.15%
GameStop Corp

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with LYEL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then LYEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
-4.32%
LYEL - HOTH
47%
Loosely correlated
+4.04%
CLRB - HOTH
41%
Loosely correlated
-0.95%
RLYB - HOTH
37%
Loosely correlated
-4.57%
RXRX - HOTH
35%
Loosely correlated
-1.91%
NRXP - HOTH
35%
Loosely correlated
-5.12%
More

LIMN and

Correlation & Price change

A.I.dvisor tells us that LIMN and SGMT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIMN and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
+87.36%
SGMT - LIMN
32%
Poorly correlated
+5.30%
AIM - LIMN
29%
Poorly correlated
-4.96%
LYEL - LIMN
25%
Poorly correlated
+4.04%
BGMSP - LIMN
23%
Poorly correlated
N/A
HOTH - LIMN
22%
Poorly correlated
-4.32%
More